Table 2.
Percentage change in age-specific invasive pneumococcal disease (IPD) incidence (2000 versus 2008)
| PCV7 (%) | PCV7SR (%) | All (%) | All less epidemic (%) | ||
|---|---|---|---|---|---|
| Including PCV7 and epidemic | Excluding PCV7 | ||||
| Age group | |||||
| <2 years | −98 | 119 | −70 | 154 | −71 |
| 2–4 years | −86 | 527 | −57 | 198 | −57 |
| 5–9 years | −42 | 0 | 1 | 154 | 30 |
| 10–14 years | −100 | 0 | 0 | 201 | −33 |
| 15–19 years | −70 | 0 | −55 | −10 | −55 |
| 20–64 years | −53 | 322 | 48 | 134 | 29 |
| 65+ years | −83 | 168 | −7 | 98 | −12 |
| Total | −76 | 246 | 3 | 134 | −9 |
PCV7 7-valent pneumococcal conjugate vaccine, PCV7SR PCV7-related serotype replacement